Chinese Drug Companies Expected To Outperform Device Makers In 2010 - Morgan Stanley Valuation Overview
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - With a strong IPO performance for the Chinese healthcare sector in 2009, the total market cap for Chinese healthcare companies has reached $145 billion with 185 companies listed globally, according to the first China Healthcare Valuation Map, developed by Morgan Stanley research group in Hong Kong